Immunotech Biopharm Ltd (HKG:6978)
Hong Kong · Delayed Price · Currency is HKD 0.4050
+0.0050 (1.25%)
Oct 9, 2026, 3:59 PM HKT
Immunotech Biopharm Market Cap
Immunotech Biopharm has a market cap or net worth of 250.09 million as of October 9, 2026. It is the 33,804th most valuable company in the world and the 1,810th biggest in Hong Kong. Its market cap has decreased by 90.92% in one year.
Market Cap
250.09M
Enterprise Value
639.25M
Revenue
n/a
Global Rank
Country Rank
#1,810 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since July 10, 2020, Immunotech Biopharm's market cap has decreased from 7.74B to 250.09M, a decrease of -96.77%. That is a compound annual growth rate of -42.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 250.09M | -86.18% |
| Dec 31, 2025 | 1.81B | 52.87% |
| Dec 31, 2024 | 1.18B | -54.00% |
| Dec 29, 2023 | 2.57B | 7.99% |
| Dec 30, 2022 | 2.38B | -72.51% |
| Dec 31, 2021 | 8.67B | 50.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kintor Pharmaceutical | 807.38M |
| Brii Biosciences | 620.79M |
| 3D Medicines | 587.75M |
| B&K Corporation | 493.57M |
| Wuhan YZY Biopharma | 484.62M |
| Uni-Bio Science Group | 417.99M |
| Sirnaomics | 413.27M |
| Transcenta Holding | 345.83M |